These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 10863321)
1. [Observing CD4 cell count and viral load alone is not enough. Value of protease inhibitors]. MMW Fortschr Med; 2000 Mar; 142 Suppl 1():81-2. PubMed ID: 10863321 [No Abstract] [Full Text] [Related]
2. Saquinavir plus ritonavir reduce viral load by 99.9 percent. Vazquez E Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983 [TBL] [Abstract][Full Text] [Related]
3. [Modification or stopping of the initial antiretroviral combination therapy with protease-inhibitors: incidence and reasons]. van Roon EN; Egberts AC; Verzijl JM; Lenderink AW; Blans M; Juttmann JR Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2231. PubMed ID: 10049095 [No Abstract] [Full Text] [Related]
5. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects. Proj Inf Perspect; 2009 Mar; (48):6. PubMed ID: 19492458 [No Abstract] [Full Text] [Related]
6. Using ritonavir with indinavir in cases of virologic failure. TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095 [No Abstract] [Full Text] [Related]
7. Data in from first head-to-head protease inhibitor. AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961 [No Abstract] [Full Text] [Related]